{"title":"利用纳米载体递送抗癌药物","authors":"Beth Lally, R. Gettens, Shabnam N. Sani","doi":"10.1109/NEBEC.2013.74","DOIUrl":null,"url":null,"abstract":"The most prevalent form of cancer treatment used today is chemotherapy, although it is widely known to be associated with frequent, high dosages and unwanted side effects. The application of nanocarriers to conventional cancer treatment aims to address these problems by encapsulating chemotherapeutic drugs within polymer or lipid nanoparticles. These drug delivery nanoparticles, known as nanocarriers, work to increase the stability and circulation time of drugs and can be used to target specific areas. This project aims to fabricate nanocarriers for the delivery of chemotherapeutic drugs in order to address the current problems of chemotherapy. These nanocarriers will reduce side effects and issues of conventional dosage forms by targeting tumor sites, releasing drug specifically and only where it is needed.","PeriodicalId":153112,"journal":{"name":"2013 39th Annual Northeast Bioengineering Conference","volume":"56 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2013-04-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Delivery of Anti-Cancer Drugs Using Nanocarriers\",\"authors\":\"Beth Lally, R. Gettens, Shabnam N. Sani\",\"doi\":\"10.1109/NEBEC.2013.74\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The most prevalent form of cancer treatment used today is chemotherapy, although it is widely known to be associated with frequent, high dosages and unwanted side effects. The application of nanocarriers to conventional cancer treatment aims to address these problems by encapsulating chemotherapeutic drugs within polymer or lipid nanoparticles. These drug delivery nanoparticles, known as nanocarriers, work to increase the stability and circulation time of drugs and can be used to target specific areas. This project aims to fabricate nanocarriers for the delivery of chemotherapeutic drugs in order to address the current problems of chemotherapy. These nanocarriers will reduce side effects and issues of conventional dosage forms by targeting tumor sites, releasing drug specifically and only where it is needed.\",\"PeriodicalId\":153112,\"journal\":{\"name\":\"2013 39th Annual Northeast Bioengineering Conference\",\"volume\":\"56 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2013-04-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"2013 39th Annual Northeast Bioengineering Conference\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1109/NEBEC.2013.74\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"2013 39th Annual Northeast Bioengineering Conference","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1109/NEBEC.2013.74","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
The most prevalent form of cancer treatment used today is chemotherapy, although it is widely known to be associated with frequent, high dosages and unwanted side effects. The application of nanocarriers to conventional cancer treatment aims to address these problems by encapsulating chemotherapeutic drugs within polymer or lipid nanoparticles. These drug delivery nanoparticles, known as nanocarriers, work to increase the stability and circulation time of drugs and can be used to target specific areas. This project aims to fabricate nanocarriers for the delivery of chemotherapeutic drugs in order to address the current problems of chemotherapy. These nanocarriers will reduce side effects and issues of conventional dosage forms by targeting tumor sites, releasing drug specifically and only where it is needed.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
